Medicare Enrolled
Dr. Gregory Emkey, M.D.
Rheumatology · Wyomissing, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Emkey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Emkey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Emkey
Dr. Gregory Emkey is a rheumatology specialist in Wyomissing, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Emkey performed 82,616 Medicare services across 3,436 unique beneficiaries.
Between the years covered by Open Payments, Dr. Emkey received a total of $177,185 from 52 pharmaceutical and/or device companies across 1079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Emkey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 17% volume in PA
$177,185 industry payments
Medicare Practice Summary
Medicare Utilization ↗82,616
Medicare services
Top 17% in PA for rheumatology
3,436
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,590 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 36,062 | $18 | $31 |
| Romosozumab injection (Evenity) for osteoporosis | 21,210 | $8 | $12 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
13,950 | $11 | $37 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
6,175 | $33 | $80 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,183 | $1 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $61 | $130 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
482 | $88 | $195 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
449 | $11 | $80 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
381 | $45 | $145 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
339 | $37 | $225 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
255 | $91 | $253 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
195 | $6 | $70 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
163 | $50 | $300 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
155 | $46 | $150 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
153 | $91 | $325 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
142 | $58 | $180 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
88 | $36 | $152 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
79 | $37 | $80 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
77 | $21 | $85 |
| New patient office visit, complex (60-74 min) | 76 | $147 | $385 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
75 | $26 | $41 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
64 | $58 | $176 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
62 | $48 | $168 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
54 | $41 | $84 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $123 | $265 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
34 | $31 | $185 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
29 | $24 | $44 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
22 | $26 | $40 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
21 | $64 | $177 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
20 | $21 | $42 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
20 | $36 | $57 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
16 | $37 | $67 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $105 | $305 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.7% high complexity
73.0% medium
2.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$177,185
Total received (2018-2024)
Avg $25,312/year across 7 years
Top 6% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,079
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152,335 (86.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,219 (8.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,631 (5.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$30,674
2023
$26,391
2022
$26,838
2021
$17,412
2020
$11,298
2019
$23,104
2018
$41,468
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$17,682
Amgen Inc.
$8,824
Janssen Biotech, Inc.
$2,616
UCB, Inc.
$245
AstraZeneca Pharmaceuticals LP
$203
ANI Pharmaceuticals, Inc.
$163
GlaxoSmithKline, LLC.
$104
Aurinia Pharma U.S., Inc.
$78
E.R. Squibb & Sons, L.L.C.
$70
Genentech USA, Inc.
$67
Novartis Pharmaceuticals Corporation
$63
Lilly USA, LLC
$61
Kyowa Kirin, Inc.
$59
Radius Health, Inc.
$53
Almatica Pharma LLC
$49
GENZYME CORPORATION
$47
Kiniksa Pharmaceuticals International, plc
$43
Fresenius Kabi USA, LLC
$41
PFIZER INC.
$40
Mallinckrodt Hospital Products Inc.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
DePuy Synthes Sales Inc.
$34
Daiichi Sankyo Inc.
$29
Novus Surgical Consultants
$27
Top 3 companies account for 94.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$63,292
ABBVIE INC.
$54,140
AbbVie Inc.
$13,905
AbbVie, Inc.
$12,737
Radius Health, Inc.
$12,672
PFIZER INC.
$8,732
Janssen Biotech, Inc.
$3,781
E.R. Squibb & Sons, L.L.C.
$858
Genentech USA, Inc.
$737
GlaxoSmithKline, LLC.
$543
UCB, Inc.
$528
Novartis Pharmaceuticals Corporation
$514
AstraZeneca Pharmaceuticals LP
$465
Lilly USA, LLC
$435
Janssen Scientific Affairs, LLC
$405
Alexion Pharmaceuticals, Inc.
$376
GENZYME CORPORATION
$365
ANI Pharmaceuticals, Inc.
$301
Celgene Corporation
$265
Aurinia Pharma U.S., Inc.
$214
Mallinckrodt Hospital Products Inc.
$195
Organon LLC
$132
DePuy Synthes Sales Inc.
$128
Horizon Therapeutics plc
$101
Flexion Therapeutics, Inc.
$95
Fresenius Kabi USA, LLC
$91
Kyowa Kirin, Inc.
$87
Mallinckrodt LLC
$87
Ferring Pharmaceuticals Inc.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
MEDEXUS PHARMA, INC.
$73
Ultragenyx Pharmaceutical Inc.
$69
Orthogenrx Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$64
Exeltis, USA Inc.
$59
SANOFI-AVENTIS U.S. LLC
$52
SOBI, INC
$51
Almatica Pharma LLC
$49
Sobi, Inc
$45
Kiniksa Pharmaceuticals International, plc
$43
Bioventus LLC
$35
Pacira Therapeutics, Inc.
$33
Kiniksa Pharmaceuticals, Ltd.
$31
Daiichi Sankyo Inc.
$29
Novus Surgical Consultants
$27
Actelion Pharmaceuticals US, Inc.
$24
Oxford Immunotec USA Inc
$19
Sandoz Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Ironwood Pharmaceuticals, Inc
$15
TerSera Therapeutics LLC
$15
Fidia Pharma USA Inc.
$13
Top 3 companies account for 74.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FORTEO · GELSYN 3 · GELSYN-3 · GenVisc 850 · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · LOREEV XR · LUMIZYME · LUPKYNIS · LYRICA · MONOVISC · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · QUZYTTIR · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TREMFYA · TSPOT TB TEST · Tavneos · TriVisc sodium hyaluronate · Truxima · Tymlos · ULTOMIRIS · Uloric · Ultomiris · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for rheumatology in PA.
Geographic Context
Rheumatologists within 10 mi
15
Per 100K population
3.5
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Emkey is a mixed practice specialist, with above-average Medicare volume (top 17% in PA), with speaking/promotional industry engagement in the top 6% of PA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Emkey experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Emkey performed 36,062 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Emkey receive payments from pharmaceutical companies?
Yes. Dr. Emkey received a total of $177,185 from 52 companies across 1,079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Emkey's costs compare to other rheumatologists in Wyomissing?
Dr. Emkey's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Emkey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Wyomissing
Browse rheumatologists in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology